AINT yields 8.25% · ABBV yields 3.67%● Live data
📍 ABBV pulled ahead of the other in Year 2
Combined, AINT + ABBV cover 4 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AINT + ABBV for your $10,000?
AINT seeks long-term capital appreciation and absolute returns by employing a dollar-neutral strategy, taking long and short positions in large-cap US stocks from the S&P 500 (SPX), determined by a proprietary, adaptive AI Model. The model continuously ranks all 500 SPX stocks daily, integrating conventional and professional wisdom, fundamental signals, regulatory interpretations, NLP-extracted financial data, and advanced machine learning to provide dynamic stock rankings. Based on these rankings, the fund selects and weights the 1014 highest- and lowest-ranked stocks, respectively, with consideration to regulatory restrictions. The fund aims to balance long and short exposures and focus on relative performance and not market direction. Leverage may be used, increasing both gains and losses. The sub-adviser oversees the AI model for technical issues but does not alter outputs. Actual fund performance may differ from model results due to timing, fees, and cash holdings for operations.
Full AINT Calculator →AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.